The submission deadline has been extended to Monday, April 4th at 11:59pm EDT.  

Prior to beginning the abstract submission, please review the information below. 

Abstract Submission Process

Short Version
All submissions require a short abstract.  Short abstracts, which will be published in Medical Physics, must not exceed 250 words.  The abstract should concisely convey key points under the headings of Purpose, Methods, Results, and Conclusions. To enable blind review, do not list any author names, institutions in the space provided

General Submission Long Abstract
Additional supplementary information in the form of a long abstract is highly recommended for all general submissions.  The long abstract should facilitate a deeper understanding of the submitted work and consist of clearly written text and up to 3 figures and/or tables. The abstract should include text with the following section headings (Innovation/Impact, Introduction, Materials and Methods, Results and Discussions, Conclusions, References), however you do not need to populate all headings for general submissions.   Under Innovation/Impact, succinctly provide a statement (one or two sentences) of the work’s innovation/impact.  The maximum number of words for the long abstract text is 750. (For reference, this represents approximately one page of text). 

All graphs, images, or multimedia elements for abstracts must be uploaded at the end of your submission.  

Presenting and Contributing Authors: You may add co-authors if there are any contributing authors.  

Note that final presentation mode assignments will be made at the discretion of the program committee. Any submission may be rejected.


Author Verification Agreement (required) 
The corresponding author must agree to the following "Author Verification Agreement" statement button in the submission process:  By checking the box, you verify that each author to be listed on the submitted abstract has contributed to the content of the abstract and consented to the submission of the said abstract.   

Conflict of Interest (required) 
Any financial relationship with sponsoring companies or organizations about whose product or services that the Author(s) are reporting must be disclosed.  If such a financial arrangement exists, a disclosure statement must be entered in the space provided after you check the box.  This policy should not discourage such support.  It is meant to allow members of the audience to form their own judgments about the presentation with the full disclosure of the facts.   

Distribution Agreement (required) 
The corresponding author must agree to the "Distribution Agreement" button in the submission process.  By checking this box, you verify that each author listed on the submitted abstract has agreed to permit the distribution of the abstract at the COMP ASM and/or via the COMP website and any other publication resulting from the ASM. Under this constraint, you also verify that all contributing authors will obtain or have obtained permission for the use of any copyrighted materials that may be presented at the COMP ASM for educational purposes from the appropriate copyright owner(s) and publisher(s). 

Abstract submission for the 2022 COMP ASM is web-based. All submitters must log into the COMP website.  If you are a COMP member, enter your email and password.  If you don’t have an account with COMP, please follow the instructions to create an account.
You will be sent a confirmation e-mail that your abstract has been submitted.  A review committee will be accessing all abstracts after the submission deadline, April 4, 2022.  You will receive an email notification of the status of your abstract by May. 

Withdrawal of Abstract Submission
Should you wish to withdraw an Abstract, requests should be sent to